Overview

Study Comparing Pathological Responses Observed on Colorectal Cancer Metastases Resected After Preoperative Bevacizumab With FOLFOX or FOLFIRI.

Status:
Completed

Trial end date:
2019-05-01

Target enrollment:

Participant gender:

Summary

The study is designed to analyze the pathological tumor response on resected colorectal cancer metastases after preoperative treatment with bevacizumab combined with FOLFOX or FOLFIRI regimen in a prospective cohort and to correlate this response with patient's outcome.

Phase:

Phase 2

Details

Lead Sponsor:

Cliniques universitaires Saint-Luc- Université Catholique de Louvain

Collaborator:

Grand Hôpital de Charleroi

Treatments:

Bevacizumab
Camptothecin
Irinotecan
Oxaliplatin